Evidence map›Paper›PMID 40281595›Full record

ArticleAlzheimer's research & therapy2025

Differential effects of aging, Alzheimer's pathology, and APOE4 on longitudinal functional connectivity and episodic memory in older adults.

Larissa Fischer, Jenna N Adams, Eóin N Molloy, Niklas Vockert, Jennifer Tremblay-Mercier, Jordana Remz, Alexa Pichet Binette, Sylvia Villeneuve, Anne Maass, PREVENT-AD Research Group

Abstract read
In one paragraph

Article in Alzheimer's research & therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Larissa FischerGerman Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany. larissa.fischer@dzne.de.ORCID 0009-0001-9936-2954
Jenna N AdamsDepartment of Neurobiology and Behavior, University of California, Irvine, USA.ORCID 0000-0002-6702-3851
Eóin N MolloyGerman Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.ORCID 0000-0002-7804-2214
Niklas VockertGerman Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.ORCID 0000-0001-5915-2517
Jennifer Tremblay-MercierStoP-AD Centre, Douglas Mental Health Institute Research Centre, McGill University, Montréal, Canada.
Jordana RemzStoP-AD Centre, Douglas Mental Health Institute Research Centre, McGill University, Montréal, Canada.
Alexa Pichet BinetteDepartment of Physiology and Pharmacology, Université de Montréal, Montréal, Canada.ORCID 0000-0001-5218-3337
Sylvia VilleneuveStoP-AD Centre, Douglas Mental Health Institute Research Centre, McGill University, Montréal, Canada.ORCID 0000-0003-2338-0467
Anne MaassGerman Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany. anne.maass@dzne.de.ORCID 0000-0002-7889-795X
PREVENT-AD Research Group

Funding

Deutsche Forschungsgemeinschaft 362321501Deutsche Forschungsgemeinschaft 425899996
6 · The paper itself

Abstract

backgroundBoth aging and Alzheimer's disease (AD) affect brain networks, with early disruptions occurring in regions involved in episodic memory. Few studies have, however, focused on distinguishing region-specific effects of AD-biomarker negative "normal" aging and early amyloid- and tau pathology on functional connectivity. Further, longitudinal studies combining imaging, biomarkers, and cognition are rare.

methodsWe assessed resting-state functional connectivity (rsFC) strength and graph measures in the episodic memory network including the medial temporal lobe (MTL), posteromedial cortex (PMC), and medial prefrontal cortex alongside cognition over two years. For this preregistered study, we included 100 older adults who were amyloid- and tau-negative using CSF and PET measurements to investigate "normal" aging, and 70 older adults who had longitudinal CSF data available to investigate functional changes related to early AD pathology. All participants were cognitively unimpaired older adults from the PREVENT-AD cohort. We used region of interest (ROI)-to-ROI bivariate correlations, graph analysis, and multiple regression models.

resultsIn the amyloid- and tau-negative sample, rsFC strength within PMC, between parahippocampal cortex and inferomedial precuneus, and between posterior hippocampus and inferomedial precuneus decreased over time. Additionally, we observed a longitudinal decrease in global efficiency. Further, there was a steeper longitudinal decrease in rsFC and global efficiency with higher baseline age particularly of parahippocampal-gyrus regions. Further, lower rsFC strength within PMC was associated with poorer longitudinal episodic memory performance. In the sample with available CSF data, a steeper increase in rsFC between anterior hippocampus and superior precuneus was related to higher baseline AD pathology. Higher MTL-PMC rsFC strength was differentially associated with episodic memory trajectories depending on APOE4 genotype.

conclusionsOur findings suggest differential effects of aging and AD pathology. Hypoconnectivity within PMC was related to aging and cognitive decline. MTL-PMC hyperconnectivity was related to early AD pathology and cognitive decline in APOE4 carriers. Future studies should investigate more diverse samples, nonetheless, our approach allowed us to identify longitudinal functional changes related to aging and early AD pathology, enhancing cross-sectional research. Hyperconnectivity has been proposed as a mechanism related to early AD pathology before, we now contribute specific functional connections to focus on in future research.

Indexed as

AgingAlzheimer DiseaseApolipoprotein E4BrainMemory, EpisodicAgedAged, 80 and overFemaleHumansLongitudinal StudiesMagnetic Resonance ImagingMaleMiddle AgedNeural PathwaysPositron-Emission Tomographytau ProteinsApolipoprotein E4tau ProteinsAgingAlzheimer’s diseaseAPOEEpisodic memoryFMRIFunctional connectivity

Identifiers

PMID40281595
PMCPMC12023467

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.